摘要
目的探讨凝血常规检查在肺癌患者中的应用价值。方法选取2017年1月至2018年1月前来我院就诊的肺癌患者30例为试验组,采用同期行体检的患者30例作为对照组。两组患者均常规检查凝血常规。观察两组患者的凝血常规情况。结果试验组患者的血浆凝血酶原时间(PT)、部分活化凝血活酶时间(APTT)及凝血时间(TT)较对照组比较差异没有统计学意义(P>0.05)。试验组和对照组患者的纤维蛋白原分别为(4.45±0.78)g/L、(2.58±0.58),两组数据比较差异具有统计学意义(P<0.05)。结论肺癌患者的纤维蛋白原明显高于同期的健康患者,对于肺癌的临床治疗具有一定意义。
Objective To investigate the application value of coagulation routine examination in patients with lung cancer.Methods 30 patients with lung cancer who came to our hospital from January 2017 to January 2018 were selected as the experimental group,and 30 patients in the same period were selected as the control group.The two groups were routinely examined for clotting routine.The clotting routine of the two groups of patients was observed.Results Compared with the control group,the plasma prothrombin time(PT),partial activated thromboplastin time(APTT)and blood coagulation time(TT)in the experimental group were no significant difference compared with the control group(P>0.05).The fibrinogen of the experimental group and the control group were(4.45±0.78)g/L and(2.58±0.58)respectively,and the difference between the two groups was statistically significant(P<0.05).Conclusion Fibrinogen in patients with lung cancer is significantly higher than that in healthy patients at the same time,which has certain significance for the clinical treatment of lung cancer.
作者
王卉媛
WANG Hui-yuan(Department of Clinical Laboratory,Dalian Traditional Chinese Medicine Hospital,Dalian 116000,China)
出处
《中国医药指南》
2019年第32期18-19,共2页
Guide of China Medicine
关键词
凝血常规
肺癌
应用价值
Clotting routine
Lung cancer
Application value
